BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 14687996)

  • 41. Is prolonged immobilization a risk factor for symptomatic venous thromboembolism in elderly bedridden patients? Results of a historical-cohort study.
    Gatt ME; Paltiel O; Bursztyn M
    Thromb Haemost; 2004 Mar; 91(3):538-43. PubMed ID: 14983230
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Thrombophilia and risk of venous thrombosis in patients with cancer.
    Decousus H; Moulin N; Quenet S; Bost V; Rivron-Guillot K; Laporte S; Mismetti P
    Thromb Res; 2007; 120 Suppl 2():S51-61. PubMed ID: 18023713
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Sex and gender issues and venous thromboembolism.
    Moores L; Bilello KL; Murin S
    Clin Chest Med; 2004 Jun; 25(2):281-97. PubMed ID: 15099889
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The prevalence of risk factors for venous thromboembolism among hospital patients.
    Anderson FA; Wheeler HB; Goldberg RJ; Hosmer DW; Forcier A
    Arch Intern Med; 1992 Aug; 152(8):1660-4. PubMed ID: 1497399
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Association between venous and arterial thrombosis: clinical implications.
    Franchini M; Mannucci PM
    Eur J Intern Med; 2012 Jun; 23(4):333-7. PubMed ID: 22560380
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Epidemiology of thrombotic risk factors: the difficulty in using clinical trials to develop a risk assessment model.
    Laporte S; Mismetti P
    Crit Care Med; 2010 Feb; 38(2 Suppl):S10-7. PubMed ID: 20083908
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Epidemiological characteristics of acute pulmonary thromboembolism in Japan.
    Yamada N; Nakamura M; Ishikura K; Ota M; Yazu T; Hiraoka N; Tanaka H; Ito M; Fujioka H; Isaka N; Nakano T
    Int Angiol; 2003 Mar; 22(1):50-4. PubMed ID: 12771856
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Risk assessment as a guide for the prevention of the many faces of venous thromboembolism.
    Caprini JA
    Am J Surg; 2010 Jan; 199(1 Suppl):S3-10. PubMed ID: 20103082
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Molecular and clinical conditions associated with venous thromboembolism in oncological patients.
    Di Micco P; Amitrano M; Niglio A; Fontanella A
    Exp Oncol; 2006 Sep; 28(3):194-7. PubMed ID: 17080011
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Venous thromboembolism's risk assessment: rationale, objectives, and methodology--the ARTE study].
    França A; De Sousa JA; Felicíssimo P; Ferreira D
    Acta Med Port; 2011 Dec; 24 Suppl 2():575-82. PubMed ID: 22849949
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Criteria for evaluating evidence that laboratory abnormalities are associated with the development of venous thromboembolism.
    Bates SM; Ginsberg JS; Straus SE; Rekers H; Sackett DL
    CMAJ; 2000 Oct; 163(8):1016-21. PubMed ID: 11068575
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Thromboembolism in travelers].
    Bihari I; Sándor T
    Orv Hetil; 2001 Nov; 142(45):2469-73. PubMed ID: 11778354
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Risk assessment of venous thromboembolism in hospitalized medical patients.
    Spyropoulos AC
    Curr Opin Pulm Med; 2010 Sep; 16(5):419-25. PubMed ID: 20592598
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Early recognition of pediatric venous thromboembolism: a risk-assessment tool.
    Prentiss AS
    Am J Crit Care; 2012 May; 21(3):178-83; quiz 184. PubMed ID: 22549574
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Acquired thrombotic risk factors in the critical care setting.
    Ortel TL
    Crit Care Med; 2010 Feb; 38(2 Suppl):S43-50. PubMed ID: 20083913
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Statins and thrombogenesis].
    Palomäki A
    Duodecim; 2011; 127(20):2131-8. PubMed ID: 22191199
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Important risk factors for venous thromboembolism. Analysis of 758 patients studied at a thrombosis center].
    Cellai AP; Marcucci R; Bialek W; Alessandrello Liotta A; Rogolino A; Gazzini A; Papi C; Casamassima C; Prisco D; Abbate R
    Minerva Cardioangiol; 1999 Dec; 47(12):533-4. PubMed ID: 10670190
    [No Abstract]   [Full Text] [Related]  

  • 58. Venous thromboembolism prophylaxis and risk assessment in medical patients.
    Arcelus JI; Candocia S; Traverso CI; Fabrega F; Caprini JA; Hasty JH
    Semin Thromb Hemost; 1991; 17 Suppl 3():313-8. PubMed ID: 1754887
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Substantial recurrence risk after venous thromboembolism provoked by minor risk factors.
    Braekkan SK; Hansen JB
    J Thromb Haemost; 2018 Sep; 16(9):1671-1673. PubMed ID: 30094929
    [No Abstract]   [Full Text] [Related]  

  • 60. Economy-class syndrome: media hype or real risk?
    Martinelli I; Battaglioli T
    Haematologica; 2003 May; 88(5):486-8. PubMed ID: 12745267
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.